Evidence map›Paper›PMID 34448381›Full record

ReviewKorean journal of radiology2021

Comprehensive Updates in the Role of Imaging for Multiple Myeloma Management Based on Recent International Guidelines.

Koeun Lee, Kyung Won Kim, Yousun Ko, Ho Young Park, Eun Jin Chae, Jeong Hyun Lee, Jin-Sook Ryu, Hye Won Chung

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Korean journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Koeun Lee *Department of Radiology, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID 0000-0001-8202-3641
Kyung Won Kim *Department of Radiology, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID 0000-0002-1532-5970
Yousun KoBiomedical Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.ORCID 0000-0002-2181-9555
Ho Young ParkDepartment of Radiology, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID 0000-0003-2318-9806
Eun Jin ChaeDepartment of Radiology, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID 0000-0002-5299-0048
Jeong Hyun LeeDepartment of Radiology, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID 0000-0002-0021-4477
Jin-Sook RyuDepartment of Nuclear Medicine, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID 0000-0002-8339-2809
Hye Won ChungDepartment of Radiology, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. chung@amc.seoul.kr.ORCID 0000-0001-5597-8143
Ulsan College · KRAsan Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnostic and treatment methods of multiple myeloma (MM) have been rapidly evolving owing to advances in imaging techniques and new therapeutic agents. Imaging has begun to play an important role in the management of MM, and international guidelines are frequently updated. Since the publication of 2015 International Myeloma Working Group (IMWG) criteria for the diagnosis of MM, whole-body magnetic resonance imaging (MRI) or low-dose whole-body computed tomography (CT) and

Indexed as

Multiple MyelomaFluorodeoxyglucose F18HumansMagnetic Resonance ImagingPositron-Emission TomographyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsWhole Body ImagingFluorodeoxyglucose F18RadiopharmaceuticalsDiagnosisLow-dose whole-body CTMultiple myelomaTreatment responseWhole-body MRI

Identifiers

PMID34448381
PMCPMC8390819
OpenAlexW3175247416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.